IP Library Granted Patent US 8,772,498
Granted Patent B2
US 8,772,498 · App. 13/801,484 · Granted Jul 8, 2014

Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof

Inventors: Alexandros Vakalopoulos (Hilden, DE); Daniel Meibom (Leverkusen, DE); Barbara Albrecht-Küpper (Wüfrath, DE); Katja Zimmermann (Düsseldorf, DE); Jörg Keldenich (Wuppertal, DE); Hans-Georg Lerchen (Leverkusen, DE); Peter Nell (Woodside, CA); Frank Süβmeier (Munich, DE); Ursula Krenz (Leichlingen, DE)
Assignee: Bayer Intellectual Property GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,772,498
App. No.
13/801,484
Granted
Jul 8, 2014
Kind
B2
Abstract

The present application relates to novel 6-alkylamino-substituted dicyanopyridines, to their amino acid ester prodrugs, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prevention of cardiovascular disorders.

Claims (72)

1. A compound of formula (VII)

wherein,

R 1 represents hydrogen or (C 1 -C 4 )-alkyl,

R 2 represents (C 1 -C 6 )-alkyl, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )-alkynyl or (C 3 -C 7 )-cycloalkyl,

where (C 1 -C 6 )-alkyl may be substituted by 1 to 3 substituents selected independently of one another from the group consisting of fluorine, chlorine, trifluoromethyl, trifluoromethoxy, (C 1 -C 4 )-alkoxy, (C 3 -C 7 )-cycloalkyl, (C 3 -C 7 )-cycloalkoxy, (C 1 -C 4 )-alkylsulfanyl and (C 1 -C 4 )-alkylsulfonyl,

and

where (C 2 -C 4 )-alkenyl and (C 2 -C 4 )-alkynyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,

and

where (C 3 -C 7 )-cycloalkyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, chlorine, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,

or

R 1 and R 2 together with the nitrogen atom to which they are attached form a 4- to 7-membered heterocycle which may contain a further heteroatom from the group consisting of N, O and S,

where the 4- to 7-membered heterocycle may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, chlorine, oxo, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,

R 4 represents hydrogen or the side group of a natural α-amino acid or its homologs or isomers,

R 5 represents hydrogen or methyl,

R 6A represents hydrogen, (C 1 -C 4 )-alkyl, or an amino protective group,

R 7A represents hydrogen, (C 1 -C 4 )-alkyl, or an amino protective group,

or

R 6A and R 7A together with the nitrogen atom to which they are attached form a 5- or 6-membered heterocycle,

where the 5- or 6-membered heterocycle may be substituted by 1 or 2 substituents independently selected from the group consisting of (C 1 -C 4 )-alkyl, amino, hydroxyl and (C 1 -C 4 )-alkoxy,

or

R 7A together with R 4 and the atoms, to which they are attached, forms a pyrrolidine or piperidine ring,

or a salt thereof.

2. The compound of claim 1 , wherein

R 1 represents hydrogen, methyl, or ethyl;

R 2 represents (C 1 -C 3 )-alkyl, cyclopropyl, or cyclobutyl,

where (C 1 -C 3 )-alkyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, chlorine, trifluoromethyl, methoxy, ethoxy, cyclopropyl, and cyclobutyl;

or

R 1 and R 2 together with the nitrogen atom to which they are attached form a 4- to 6-membered heterocycle which may contain a further heteroatom from the group consisting of N, O, and S,

where the 4- to 6-membered heterocycle may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, trifluoromethyl, methyl, ethyl, methoxy, and ethoxy;

R 4 represents methyl or 3-aminopropan-1-yl;

R 5 represents hydrogen;

R 6A represents hydrogen, methyl, or an amino protecting group; and

R 7A represents hydrogen, or an amino protecting group; or

R 7A together with R 4 and the atoms, to which they are attached, forms a pyrrolidine ring.

3. The compound of claim 1 , wherein

R 1 represents hydrogen, methyl, or ethyl;

R 2 represents methyl, ethyl, or n-propyl, where methyl, ethyl, and n-propyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, trifluoromethyl, and methoxy;

or

R 1 and R 2 together with the nitrogen atom to which they are attached form an azetidinyl, pyrrolidinyl, or piperidinyl ring, where the azetidinyl, and piperidinyl ring may be substituted by a methoxy substituent.

4. The compound of claim 1 , wherein

R 1 represents hydrogen, methyl or ethyl,

R 2 represents (C 1 -C 3 )-alkyl, cyclopropyl or cyclobutyl,

where (C 1 -C 3 )-alkyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, chlorine, trifluoromethyl, methoxy, ethoxy, cyclopropyl and cyclobutyl.

5. A compound of formula (VIII)

wherein

R 1 represents hydrogen or (C 1 -C 4 )-alkyl,

R 2 represents (C 1 -C 6 )-alkyl, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )-alkynyl or (C 3 -C 7 )-cycloalkyl,

where (C 1 -C 6 )-alkyl may be substituted by 1 to 3 substituents selected independently of one another from the group consisting of fluorine, chlorine, trifluoromethyl, trifluoromethoxy, (C 1 -C 4 )-alkoxy, (C 3 -C 7 )-cycloalkyl, (C 3 -C 7 )-cycloalkoxy, (C 1 -C 4 )-alkylsulfanyl and (C 1 -C 4 )-alkylsulfonyl,

where (C 2 -C 4 )-alkenyl and (C 2 -C 4 )-alkynyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,

and

where (C 3 -C 7 )-cycloalkyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, chlorine, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy,

or

R 1 and R 2 together with the nitrogen atom to which they are attached form a 4- to 7-membered heterocycle which may contain a further heteroatom from the group consisting of N, O and S,

where the 4- to 7-membered heterocycle may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, chlorine, oxo, trifluoromethyl, (C 1 -C 4 )-alkyl, trifluoromethoxy and (C 1 -C 4 )-alkoxy;

L 2 represents (C 2 -C 6 )-alkanediyl;

R 17A represents hydrogen, (C 1 -C 4 )-alkyl, or an amino protective group, and

R 18A represents hydrogen, (C 1 -C 4 )-alkyl, or an amino protective group; or

R 17 and R 18 together with the nitrogen atom to which they are attached form a 5- or 6-membered heterocycle, where the 5- or 6-membered heterocycle may be substituted by 1 or 2 substituents independently selected from the group consisting of (C 1 -C 4 )-alkyl, amino, hydroxyl, and (C 1 -C 4 )-alkoxy.

6. The compound of claim 5 , wherein

R 1 represents hydrogen, methyl, or ethyl;

R 2 represents (C 1 -C 3 )-alkyl, cyclopropyl, or cyclobutyl, where (C 1 -C 3 )-alkyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, chlorine, trifluoromethyl, methoxy, ethoxy, cyclopropyl, and cyclobutyl;

or

R 1 and R 2 together with the nitrogen atom to which they are attached form a 4- to 6-membered heterocycle which may contain a further heteroatom from the group consisting of N, O, and S,

where the 4- to 6-membered heterocycle may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, trifluoromethyl, methyl, ethyl, methoxy, and ethoxy;

L 2 represents ethane-1,2-diyl or propane-1,3-diyl,

R 17 represents hydrogen, methyl, or an amino protecting group; and

R 18 represents hydrogen, methyl, or an amino protecting group.

7. The compound of claim 5 , wherein

R 1 represents hydrogen, methyl, or ethyl;

R 2 represents methyl, ethyl, or n-propyl, where methyl, ethyl, and n-propyl may be substituted by 1 or 2 substituents selected independently of one another from the group consisting of fluorine, trifluoromethyl, and methoxy;

or

R 1 and R 2 together with the nitrogen atom to which they are attached form an azetidinyl, pyrrolidinyl, or piperidinyl ring, where the azetidinyl, and piperidinyl ring may be substituted by a methoxy substituent.

Assignments (3)
CHANGE OF NAME Recorded Jun 16, 2014
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 033181/0852 →
CONFIRMATORY ASSIGNMENT Recorded Jun 16, 2014
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 033181/0974 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2014
From: VAKALOPOULOS, ALEXANDROS, DR.; MEIBOM, DANIEL, DR.; ALBRECHT-KUPPER, BARBARA, DR.; ZIMMERMANN, KATJA, DR.; KELDENICH, JOERG, DR.; LERCHEN, HANS-GEORG, DR.; NELL, PETER, DR.; SUSSMEIER, FRANK; KRENZ, URSULA, DR.
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 032797/0315 →
Priority Claims (1)
DE 10 2009 006 602 · Jan 29, 2009 · national
Continuity (2)
Continuation 12697000 · Jan 29, 2010
Related Publication 20130267700A1 · Oct 10, 2013